Literature DB >> 23759343

The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis.

Cynthia E Fisher1, A Michal Stevens, Wendy Leisenring, Steven A Pergam, Michael Boeckh, Tobias M Hohl.   

Abstract

We examined the relationship between serum and bronchoalveolar lavage (BAL) galactomannan index (GMI) values and mortality in allogeneic hematopoietic cell transplant recipients with invasive pulmonary aspergillosis. Using a clinical sign and symptom-initiated approach, we found that the serum but not the BAL GMI level correlated with 42- and 180-day patient mortality.

Entities:  

Keywords:  Aspergillus; aspergillosis; galactomannan; mortality; transplant

Mesh：

Substances：

Year:  2013        PMID： 23759343      PMCID： PMC3765008          DOI： 10.1093/cid/cit393

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Factors associated with mortality in transplant patients with invasive aspergillosis.

Authors:  John W Baddley; David R Andes; Kieren A Marr; Dimitrios P Kontoyiannis; Barbara D Alexander; Carol A Kauffman; Robert A Oster; Elias J Anaissie; Thomas J Walsh; Mindy G Schuster; John R Wingard; Thomas F Patterson; James I Ito; O Dale Williams; Tom Chiller; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

2.  Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis.

Authors:  Louis Y A Chai; Bart-Jan Kullberg; Elizabeth M Johnson; Steven Teerenstra; Lay Wai Khin; Alieke G Vonk; Johan Maertens; Olivier Lortholary; Peter J Donnelly; Haran T Schlamm; Peter F Troke; Mihai G Netea; Raoul Herbrecht
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

3.  Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease.

Authors:  François Boutboul; Corinne Alberti; Thierry Leblanc; Annie Sulahian; Eliane Gluckman; Francis Derouin; Patricia Ribaud
Journal:  Clin Infect Dis       Date:  2002-02-20       Impact factor: 9.079

4.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

5.  Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.

Authors:  Arlo Upton; Katharine A Kirby; Paul Carpenter; Michael Boeckh; Kieren A Marr
Journal:  Clin Infect Dis       Date:  2007-01-09       Impact factor: 9.079

6.  Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.

Authors:  I Hadrich; F Makni; F Cheikhrouhou; S Neji; I Amouri; H Sellami; H Trabelsi; H Bellaaj; M Elloumi; A Ayadi
Journal:  Pathol Biol (Paris)       Date:  2011-12-10

7.  Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients.

Authors:  Anne Bergeron; Raphaël Porcher; Jean Menotti; Jean Louis Poirot; Karine Chagnon; Anne Vekhoff; Muriel Cornet; Françoise Isnard; Emmanuel Raffoux; Benoit Brethon; Claire Lacroix; Sophie Touratier; Jean Paul Latgé; Claire Bouges-Michel; Abdellatif Tazi; Francis Derouin; Patricia Ribaud; Annie Sulahian
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

8.  Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Authors:  Christoph Kahl; Barry E Storer; Brenda M Sandmaier; Marco Mielcarek; Michael B Maris; Karl G Blume; Dietger Niederwieser; Thomas R Chauncey; Stephen J Forman; Edward Agura; Jose F Leis; Benedetto Bruno; Amelia Langston; Michael A Pulsipher; Peter A McSweeney; James C Wade; Elliot Epner; Finn Bo Petersen; Wolfgang A Bethge; David G Maloney; Rainer Storb
Journal:  Blood       Date:  2007-06-26       Impact factor: 22.113

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients.

Authors:  Johan Maertens; Kristel Buvé; Koen Theunissen; Wouter Meersseman; Eric Verbeken; Gregor Verhoef; Johan Van Eldere; Katrien Lagrou
Journal:  Cancer       Date:  2009-01-15       Impact factor: 6.860
View more
  20 in total

1.  Reply to King and Stover.

Authors:  Cynthia E Fisher; Michael Boeckh; Tobias M Hohl
Journal:  Clin Infect Dis       Date:  2013-11-26       Impact factor: 9.079

2.  Reply to Mikulska et al.

Authors:  Cynthia E Fisher; Wendy Leisenring; Michael Boeckh; Tobias M Hohl
Journal:  Clin Infect Dis       Date:  2013-09-17       Impact factor: 9.079

Review 3.  Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.

Authors:  Dimitrios P Kontoyiannis; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2014-11-15       Impact factor: 9.079

Review 4.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

5.  Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation.

Authors:  Cynthia E Fisher; Tobias M Hohl; Wenhong Fan; Barry E Storer; David M Levine; Lu Ping Zhao; Paul J Martin; Edus H Warren; Michael Boeckh; John A Hansen
Journal:  Blood       Date:  2017-03-07       Impact factor: 22.113

6.  The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.

Authors:  Stacey R Rose; Saraschandra Vallabhajosyula; Miguel G Velez; Daniel P Fedorko; Mark J VanRaden; Juan C Gea-Banacloche; Michail S Lionakis
Journal:  J Infect       Date:  2014-05-04       Impact factor: 6.072

Review 7.  Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.

Authors:  Markus Ruhnke; Stefan Schwartz
Journal:  Ther Adv Hematol       Date:  2016-07-01

8.  Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies.

Authors:  Sachiko Seo; Christian Renaud; Jane M Kuypers; Charles Y Chiu; Meei-Li Huang; Erik Samayoa; Hu Xie; Guixia Yu; Cynthia E Fisher; Ted A Gooley; Steven Miller; Robert C Hackman; David Myerson; Ruth H Sedlak; Yae-Jean Kim; Takahiro Fukuda; David N Fredricks; David K Madtes; Keith R Jerome; Michael Boeckh
Journal:  Blood       Date:  2015-04-27       Impact factor: 22.113

9.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

10.  Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis.

Authors:  C E Fisher; A M Stevens; W Leisenring; S A Pergam; M Boeckh; T M Hohl
Journal:  Transpl Infect Dis       Date:  2014-04-12       Impact factor: 2.228
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.